Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately
The FDA has categorized this as a Class I recall. If patients update their phone or watch apps as needed, they can continue to use these devices like normal.
Cardiologist sues hospital after he was allegedly let go for sharing safety concerns
The veteran interventional cardiologist claims he was pushed out after repeatedly asking for more coverage from cardiothoracic surgeons in addition to other improvements. The hospital, meanwhile, described the lawsuit as a “collection of false allegations."
Why all heart patients should be vaccinated against the flu, COVID-19, RSV
The American College of Cardiology has shared new recommendations highlighting the protective benefits of a variety of vaccines. The new guidance also examines how to speak with patients who are hesitant to be vaccinated.
Heart surgeons see more potential in AI than colleagues from other fields
Cardiac surgeons see significant value in AI's ability to assist clinicians with administrative tasks and patient selection. When it comes to making clinical decisions, however, there is still a certain amount of skepticism.
New Apple Watch Ultra 3 makes early hypertension detection a priority
"This tool empowers patients and clinicians to work together, putting prevention at the center of care," said Ami B. Bhatt, MD, ACC chief innovation officer. "What we really want to do is create patient agency and reach as many people as we can for earlier detection of high blood pressure."

Consensus document aims to bring ‘coherence’ to PFO treatment

Eight European scientific societies joined forces to produce what they say is the first interdisciplinary position paper to help clinicians manage patients with patent foramen ovales (PFOs).

Bleeding avoidance strategies could save hospitals nearly $5K per PCI

Physicians successfully reversed the bleeding risk-treatment paradox in percutaneous coronary intervention (PCI) by prioritizing risk-concordant use of bleeding avoidance strategies like bivalirudin, radial access and vascular closure devices, according to a report published Oct. 31 in the Journal of the American Heart Association.

Researchers ID blood biomarker for stable HFpEF

Researchers have discovered a novel biomarker in stable, ambulatory patients with heart failure with preserved ejection fraction (HFpEF), a finding which may lead to earlier diagnoses of HFpEF.

5 things to look for at AHA.18

With the American Heart Association’s 2018 Scientific Sessions set for Nov. 10-12 in Chicago, two co-chairs of the programming committee previewed the themes of the meeting, its most anticipated clinical trials and the two new guidelines that will be unveiled.

Another antihypertensive drug recalled over possible cancer risk

ScieGen Pharmaceuticals has issued a recall of the blood pressure drug irbesartan after lab testing revealed a carcinogenic impurity, the FDA announced in a MedWatch Safety Alert.

What the Apple Heart Study looks like 1 year later

A Stanford- and Apple-led atrial fibrillation study of more than 400,000 U.S. residents—the largest AFib screening effort to date—has entered its final phase of data collection, the company announced Nov. 1. The trial is expected to wrap up early next year.

SAVR volumes alone not predictive of TAVR outcomes—but combined experience is

Hospitals offering transcatheter aortic valve replacement (TAVR) tend to produce the best survival outcomes when both TAVR and surgical AVR (SAVR) caseloads remain high, according to a study published Oct. 31 in JAMA Cardiology.

Dialysis raises short-term death risk in kidney patients undergoing TAVI

Kidney dialysis is an independent predictor of mortality in end-stage renal disease (ESRD) patients undergoing transcatheter aortic valve implantation (TAVI), according to a seven-year trial of 2,000 men and women in Karlsruhe, Germany.

Clinical

Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately

Cardiologist sues hospital after he was allegedly let go for sharing safety concerns

Why all heart patients should be vaccinated against the flu, COVID-19, RSV

Heart surgeons see more potential in AI than colleagues from other fields

New Apple Watch Ultra 3 makes early hypertension detection a priority